# TGA (Thrombin Generation Assay) and Prophylaxis in Haemophilia

> **NCT02781766** · NA · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 50 (estimated)

## Conditions studied

- Haemophilia A

## Interventions

- **OTHER:** Thrombin generation measurement.

## Key facts

- **NCT ID:** NCT02781766
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08-08
- **Primary completion:** 2019-09-08
- **Final completion:** 2019-09-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02781766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02781766, "TGA (Thrombin Generation Assay) and Prophylaxis in Haemophilia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02781766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*